Nordic Pharma, Inc.
Premangsu Hijli is an experienced R&D leader in analytical development and validation, currently serving as Director at Amring Pharmaceuticals Inc. since March 2021. Previously, Premangsu held the position of Senior Principal Scientist at Nevakar Inc. from March 2019 to February 2021 and worked as Manager of Analytical Development at Renaissance Pharmaceuticals from April 2015 to February 2019. Premangsu has a proven track record in guiding products from moderate to high complexity through various stages, including project initiation and commercial launch. Educational qualifications include a Ph.D. in Pharmaceutical Sciences from Mumbai University and studies at St. Xavier's College.
This person is not in any teams
Nordic Pharma, Inc.
Nordic Pharma, Inc., subsidiary of Nordic Group B.V., is partnered with well-established global biopharmaceutical companies and is uniquely positioned to leverage its expertise in bringing biotechnology derived medicines, sterile manufacturing and other state-of-the-art technologies to the marketplace.